Drug interaction review methods and systems
US10366462B1 · kind B1 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 26, 2013 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | Jul 26, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H70/40
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods and systems for drug interaction review are described. In an example embodiment, a prescription request is received for a prescription drug. The prescription drug is associated with a prescription. A determination that the prescription drug is a controlled substance is made. Pharmacy claims data is analyzed to determine whether past claims adjudication data is associated with a patient controlled substance identifier. The patient controlled substance identifier is associated with a patient that has been prescribed the prescription drug through the prescription without identifying the patient as being a member of a benefit manager. The prescription request is evaluated based on a determination that the past claims adjudication data is associated with the patient controlled substance identifier. A notification is generated based on evaluation of the prescription request. Additional methods and systems are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.